ARCHIVES

NCI Barred PI Wolmark And Its Own Prevention Staff From Ad Hod Meeting.

This article is from The Cancer Letter archive.

Vol. 33 No. 15 | April 20, 2007

Download PDF Visit The Full Archive

Related Articles

Patients Prefer Silicone Over Saline Implants

November 26, 2010

J&J, Amgen Settle Lawsuit Over ESAs As FDA Prepares Another Label Change.

July 18, 2008

FDA Approves DNA Test For Two Types of HPV

March 27, 2009

Obey Erred On Criticism Of Pap Test Cost, FCRC Construction

August 10, 1979

Reimbursement Policy By Philadelphia Blue Cross Further Explained

April 21, 1989

Vidaza For MDS Approved; sNDAs for Taxotere, Gemzar

May 28, 2004